PubMed
Enclomiphene citrate stimulates testosterone production while maintaining sperm density in hypogonadal men
Kim et al., 2013
Hormonal & EndocrineInvestigational / RxC
Enclomiphene
Androxal
SERM used in endocrine protocols to stimulate LH/FSH and endogenous testosterone.
Observational report only — live community data. Not medical advice. Does not recommend doses, protocols, or treatments.
- Studies cited
- 4
- Research grade
- C
- Experience
- 56
- Activity
- 64
Overall check-ins
Trackers & reports
Overview
About Enclomiphene
SERM used in endocrine protocols to stimulate LH/FSH and endogenous testosterone.
- Category
- Hormonal & Endocrine
- Regulatory status
- Investigational / Rx
- Also known as
- Androxal
- Self-reports
- 25
Community
What 25 users report
25 community reports
Overall experience
From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Favorable 3% · Mixed 97% · Unfavorable overall 0%
Most reported benefits
Benefits users selected when logging a favorable or mixed check-in.
Libido
147
Most logged side effects
Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Headache
75
Nausea
68
Self-reported dose per injection
Median bucket: 2+ mg · Most common: 2+ mg
Reports span 2 to ≥ 2 mg (open-ended top bucket)
2+ mg
147
Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.
Commonly stacked with
How repeat users are trending
Among repeat reporters, 81% said they felt similar to their last entry, 19% more positive, and 0% more negative.
Overall, repeat reporters leaned more positive than their previous entry.
Median gap between entries: 164 days · Based on 21 repeat reporters
Research
Cited research (3)
Source
PubMed
Testosterone Restoration by Enclomiphene Citrate in Men with Secondary Hypogonadism: Pharmacodynamics and Pharmacokinetics
Wiehle et al., 2013
PubMed
Enclomiphene citrate for the treatment of secondary male hypogonadism
Rodriguez et al., 2016
Tools
Explore more
Explore
More ways to learn about Enclomiphene from observational PeptIQ data.
Compare with
Related peptides
Help
Frequently asked
What do PeptIQ users report about Enclomiphene?
This page summarizes 25 anonymized self-reports from PeptIQ users who track Enclomiphene, including commonly reported effects and co-tracked peptides. These are observational patterns, not clinical outcomes.
How do side effects relate to overall experience for Enclomiphene?
PeptIQ separates overall check-in ratings (favorable, mixed, or unfavorable) from logged side effects like nausea or fatigue. Users often report benefits and side effects in the same check-in — a high experience score does not mean zero side effects were noted.
What research is cited for Enclomiphene?
3 sources are linked on this page, including PubMed articles, clinical trial registries, and FDA labels where applicable. Citations describe published research — not recommendations.
Is Enclomiphene safe to use?
This wiki does not assess safety or recommend use. Enclomiphene is listed as Investigational / Rx. Consult a licensed clinician for personal medical decisions.
What are the purported benefits and uses of Enclomiphene?
Research, primarily in animal models, suggests Enclomiphene may have a wide range of therapeutic potentials due to its ability to promote angiogenesis (formation of new blood vessels), stimulate collagen synthesis, and modulate inflammatory responses.
SourceWhat is the legal status of Enclomiphene?
Enclomiphene is not approved by the FDA for any human use. There is no legal basis for selling it as a drug, food, or dietary supplement in the United States. The FDA has classified Enclomiphene as a Category 2 bulk drug substance, which explicitly prohibits licensed compounding pharmacies from using it in compounded medications.
SourceWhat are the known or theoretical side effects and risks of Enclomiphene?
The safety and effectiveness of Enclomiphene have not been thoroughly evaluated in humans through rigorous clinical trials. This lack of human data means that safe dosages, short-term side effects, and long-term health consequences are largely unknown.
SourceWhat is the current state of research on Enclomiphene?
While there are over 200 published studies on Enclomiphene, the vast majority are animal or in vitro (cell) studies. These preclinical studies consistently show positive results across various tissue types. However, there is a significant lack of comprehensive human clinical trial data.
Source